Adoption Increases for VeriTeQ’s “Q Inside” Breast Implant Safety Technology
July 17 2014 - 8:00AM
Business Wire
More than 800 Women in Europe and Japan Have
Received Motiva Implant Matrix Breast Implants with VeriTeQ’s Q
Inside Safety Technology in Past Four Months
VeriTeQ’s CEO Scott R. Silverman to present
today at RedChip Companies’ Global Online CEO Conference at 11 am
ET
VeriTeQ Corporation (“VeriTeQ”) (OTC Markets: VTEQ), a provider
of implantable medical device identification and radiation dose
measurement technologies, announced today that the adoption of its
Q Inside Safety Technology™ continues to increase across Europe.
There are now more than 800 women in Europe and Japan who have
received Motiva Implant Matrix® breast implants, manufactured by
VeriTeQ’s customer Establishment Labs, S.A. (“EL”), with VeriTeQ’s
Q Inside Safety Technology. Motiva Implant Matrix® breast implants
with Q Inside Safety Technology can be safely and accurately
identified from outside of the body in a physician’s office.
VeriTeQ’s FDA cleared Q Inside Safety Technology acts as an
electronic serial number in breast implants and other implantable
and reusable medical devices to provide physicians and patients
access to secure online databases to retrieve device-specific data,
such as serial number, manufacturer name, date of manufacture, lot
number, volume, size, and other data from the medical device
manufacturer. Q Inside Safety Technology may also provide an extra
level of protection to the patient in the event of a recall or
other safety event.
EL’s Motiva Implant Matrix® Ergonomix™, VelvetSurface® PLUS, and
SilkSurface® PLUS, all with VeriTeQ’s Q Inside Safety Technology,
have received CE Mark approval, which enables EL to market its
Motiva Implant Matrix® breast implants to patients in 28 countries
in the European Union.
“We are pleased with the widespread physician and patient
acceptance of the combination of EL’s advanced breast implants and
our important medical device identification technology,” said Scott
R. Silverman, VeriTeQ’s Chairman and Chief Executive Officer. “We
believe that Q Inside Safety Technology sets EL’s Motiva Implant
Matrix® breast implants apart from its competitors, offering
distinct advantages when it comes to both patient safety and device
quality.”
Mr. Silverman will present today at 11:00 am ET RedChip
Companies’ Global Online CEO Conference. To listen to the
presentation and participate in the live question and answer
session, please visit http://www.redchip.com.
About VeriTeQ
VeriTeQ develops innovative, proprietary RFID technologies for
implantable medical device identification, and dosimeter
technologies for use in radiation therapy treatment. VeriTeQ offers
the world's first FDA cleared RFID microchip technology that can be
used to identify implantable medical devices, in vivo, on demand,
at the point of care. VeriTeQ's dosimeters provide patient safety
mechanisms while measuring and recording the dose of radiation
delivered to a patient in real time. For more information on
VeriTeQ, please visit www.veriteqcorp.com.
About EL
Establishment Labs is a privately held, global breast, body and
facial aesthetic company with offices in Florida, Costa Rica and
Belgium, that designs, develops, manufactures and markets an
innovative product portfolio consisting of advanced silicone-filled
breast (www.motivaimplants.com) and body shaping implants.
Utilizing only the highest quality of medical grade silicones, the
CE-marked Motiva Implant Matrix® line is rigorously scrutinized by
professional Quality Engineers throughout the entire manufacturing
process. All its products are manufactured in full compliance with
ISO and EU requirements, and are certified under the Medical Device
Directive 93/42/EEC. For more information on EL, please visit
www.establishmentlabs.com.
Statements in this press release about our future expectations,
including the likelihood that Q Inside Safety Technology may also
provide an extra level of protection to the patient in the event of
a recall or other safety event; the likelihood that Q Inside Safety
Technology sets EL’s Motiva Implant Matrix® breast implants apart
from its competitors, offering distinct advantages when it comes to
both patient safety and device quality; constitute "forward-looking
statements" within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934, and as
that term is defined in the Private Litigation Reform Act of 1995.
Such forward-looking statements involve risks and uncertainties and
are subject to change at any time, and our actual results could
differ materially from expected results. These risks and
uncertainties include, without limitation, VeriTeQ’s ability to
raise capital; as well as other risks. Additional information about
these and other factors may be described in VeriTeQ’s Form 10-K,
filed on April 15, 2014, and Forms 10-Q, filed on May 14, 2014,
November 14, 2013, and August 9, 2013, and future filings with the
Securities and Exchange Commission The Company undertakes no
obligation to update or release any revisions to these
forward-looking statements to reflect events or circumstances after
the date of this statement or to reflect the occurrence of
unanticipated events, except as required by law.
VeriTeQAllison Tomek,
561-846-7003atomek@veriteqcorp.comorRedChip CompaniesBrendan
Hopkins, 1-800-RED-CHIP (733-2447) Ext 134Bhopkins@redchip.com
VeriTeQ (CE) (USOTC:VTEQ)
Historical Stock Chart
From Apr 2024 to May 2024
VeriTeQ (CE) (USOTC:VTEQ)
Historical Stock Chart
From May 2023 to May 2024